Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Varela

Showing results (31-40 of 132) with videos related to

Pageof 14
Sort By:
Revista Espanola De Medicina Nuclear|November 21, 2007
[Effectiveness of 123I-ioflupane (DaTSCAN) in the diagnosis of Parkinsonian syndromes. A systematic review]J Puñal Riobóo, L Varela Lema, A Serena Puig, et al.
Archivos De La Sociedad Espanola De Oftalmologia|March 6, 2022
Uveitis intermedia as the initial presentation of a primary lymphoma of the central nervous systemM V Giménez, A Pappolla, L Varela, et al.
Contraception|August 24, 1999
Early abortion with 800 micrograms of misoprostol by the vaginal routeJ L Esteve, L Varela, A Velazco, et al.
Revista Clinica Espanola|September 1, 1993
[Type I familial pseudohypoparathyroidism: clinical and hormonal study]F J Arrieta, P Saavedra, C Alvarez, et al.
Contraception|May 20, 1998
Oral methotrexate and vaginal misoprostol for early abortionJ L Carbonell, L Varela, A Velazco, et al.
Behavior Research Methods|June 23, 2021
GFMT2: A psychometric measure of face matching abilityDavid White, Daniel Guilbert, Victor P L Varela, et al.
Archivos De La Sociedad Espanola De Oftalmologia|February 28, 2021
Uveitis intermedia as the initial presentation of a primary lymphoma of the central nervous systemM V Giménez, A Pappolla, L Varela, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|June 3, 2000
Vaginal misoprostol 600 microg for early abortionJ L Carbonell, L Varela, A Velazco, et al.
Contraception|May 26, 1999
A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortionM D Creinin, J L Carbonell, J L Schwartz, et al.
Maturitas|September 1, 1995
Evidence that the loss of bone mass induced by GnRH agonists is not totally recoveredR Revilla, M Revilla, E R Hernández, et al.
Pageof 14

Showing results (31-40 of 132) with videos related to

Sort By:
Pageof 14
Revista Espanola De Medicina Nuclear|November 21, 2007
[Effectiveness of 123I-ioflupane (DaTSCAN) in the diagnosis of Parkinsonian syndromes. A systematic review]J Puñal Riobóo, L Varela Lema, A Serena Puig, et al.
Archivos De La Sociedad Espanola De Oftalmologia|March 6, 2022
Uveitis intermedia as the initial presentation of a primary lymphoma of the central nervous systemM V Giménez, A Pappolla, L Varela, et al.
Contraception|August 24, 1999
Early abortion with 800 micrograms of misoprostol by the vaginal routeJ L Esteve, L Varela, A Velazco, et al.
Revista Clinica Espanola|September 1, 1993
[Type I familial pseudohypoparathyroidism: clinical and hormonal study]F J Arrieta, P Saavedra, C Alvarez, et al.
Contraception|May 20, 1998
Oral methotrexate and vaginal misoprostol for early abortionJ L Carbonell, L Varela, A Velazco, et al.
Behavior Research Methods|June 23, 2021
GFMT2: A psychometric measure of face matching abilityDavid White, Daniel Guilbert, Victor P L Varela, et al.
Archivos De La Sociedad Espanola De Oftalmologia|February 28, 2021
Uveitis intermedia as the initial presentation of a primary lymphoma of the central nervous systemM V Giménez, A Pappolla, L Varela, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|June 3, 2000
Vaginal misoprostol 600 microg for early abortionJ L Carbonell, L Varela, A Velazco, et al.
Contraception|May 26, 1999
A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortionM D Creinin, J L Carbonell, J L Schwartz, et al.
Maturitas|September 1, 1995
Evidence that the loss of bone mass induced by GnRH agonists is not totally recoveredR Revilla, M Revilla, E R Hernández, et al.
Pageof 14